ADGRG1 Is a Predictor of Chemoresistance and Poor Survival in Cervical Squamous Carcinoma

BACKGROUND: Cisplatin is the first-line chemotherapy for cervical cancer. Cisplatin resistance has always been one of the most significant barriers to acquiring better outcomes. However, the complex molecular mechanisms accounting for the phenomenon are not completely clear. METHODS: Construction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuo, Guo, Kui, Liang, Ying, Wang, Kun, Liu, Shuyan, Yang, Xingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340018/
https://www.ncbi.nlm.nih.gov/pubmed/34367958
http://dx.doi.org/10.3389/fonc.2021.671895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340018/
https://www.ncbi.nlm.nih.gov/pubmed/34367958
http://dx.doi.org/10.3389/fonc.2021.671895

Ejemplares similares